Evidence map›Paper›PMID 21926474›Full record

ArticleCell cycle (Georgetown, Tex.)2011

Elite control of HIV: p21 (waf-1/cip-1) at its best.

Xu G Yu, Mathias Lichterfeld

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xu G Yu
Mathias Lichterfeld

Funding

Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 InfectionR01AI078799 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2008 to 2017
$4.1M
Innate resistance of CD4 T cells to HIV-1 infection in elite controllersR21AI093203 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LICHTERFELD, MATHIAS · 2011 to 2012
$487k
NIAID NIH HHS R01 AI078799NIAID NIH HHS R21 AI093203
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cyclin-Dependent Kinase 9Cyclin-Dependent Kinase Inhibitor p21HIV InfectionsHumansRNA InterferenceRNA, MessengerRNA Polymerase IIRNA, Small InterferingVirus ReplicationCyclin-Dependent Kinase 9Cyclin-Dependent Kinase Inhibitor p21RNA, MessengerRNA Polymerase IIRNA, Small Interfering

Identifiers

PMID21926474
PMCPMC3688546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.